GL1X · GenesisL1 explorer

Research workbench

Lxrbeta ligand binding domain in complex with small molecule inhibitors

Analyse Lxrbeta ligand binding domain in complex with small molecule inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6S5K
Type
protein
Length
223 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Oxysterols receptor lxr-beta
UniProt
P55055
Ligands
KWE
Pockets
3 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AOxysterols receptor lxr-betaprotein22372% helix, 3% strandP55055

Ligands and binding sites

  • KWE · 3-(4-phenylbutylamino)-1,4-bis(phenylmethyl)pyrrole-2, 5-dione · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12780.820.9337KWE
2940.370.7516empty
3920.370.7621empty

Compared structures

  • 6S5K · LXRbeta ligand binding domain in complex with small molecule inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • P55055 · AlphaFold monomer V2.0 prediction for oxysterols receptor lxr-beta (P55055) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.